Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Reville PK"'
Autor:
Fiskus W; The University of Texas MD Anderson Cancer Center, Houston, TX., Piel J; Foghorn Therapeutics, Cambridge, MA., Collins M; Foghorn Therapeutics, Cambridge, MA., Hentemann M; Foghorn Therapeutics, Cambridge, MA., Cuglievan B; The University of Texas MD Anderson Cancer Center, Houston, TX., Mill CP; The University of Texas MD Anderson Cancer Center, Houston, TX., Birdwell CE; The University of Texas MD Anderson Cancer Center, Houston, TX., Das K; The University of Texas MD Anderson Cancer Center, Houston, TX., Davis JA; The University of Texas MD Anderson Cancer Center, Houston, TX., Hou H; The University of Texas MD Anderson Cancer Center, Houston, TX., Jain A; Baylor College of Medicine, Houston, TX., Malovannaya A; Baylor College of Medicine, Houston, TX., Kadia TM; The University of Texas MD Anderson Cancer Center, Houston, TX., Daver N; The University of Texas MD Anderson Cancer Center, Houston, TX., Sasaki K; The University of Texas MD Anderson Cancer Center, Houston, TX., Takahashi K; The University of Texas MD Anderson Cancer Center, Houston, TX., Hammond D; The University of Texas MD Anderson Cancer Center, Houston, TX., Reville PK; The University of Texas MD Anderson Cancer Center, Houston, TX., Wang J; The University of Texas MD Anderson Cancer Center, Houston, TX., Loghavi S; The University of Texas MD Anderson Cancer Center, Houston, TX., Sen R; Active Motif, Carlsbad, CA., Ruan X; The University of Texas MD Anderson Cancer Center, Houston, TX., Su X; The University of Texas MD Anderson Cancer Center, Houston, TX., Flores LB; The University of Texas MD Anderson Cancer Center, Houston, TX., DiNardo CD; The University of Texas MD Anderson Cancer Center, Houston, TX., Bhalla KN; The University of Texas MD Anderson Cancer Center, Houston, TX.
Publikováno v:
Blood [Blood] 2024 May 16; Vol. 143 (20), pp. 2059-2072.
Autor:
Deng Q; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lakra P; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gou P; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Yang H; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Meydan C; Department of Medicine and Weill Cornell Cancer Center, Weill Cornell Medicine, New York, NY, USA., Teater M; Department of Medicine and Weill Cornell Cancer Center, Weill Cornell Medicine, New York, NY, USA., Chin C; Department of Medicine and Weill Cornell Cancer Center, Weill Cornell Medicine, New York, NY, USA., Zhang W; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Dinh T; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hussein U; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Li X; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Rojas E; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Liu W; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Reville PK; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kizhakeyil A; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Barisic D; Department of Medicine and Weill Cornell Cancer Center, Weill Cornell Medicine, New York, NY, USA., Parsons S; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wilson A; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Henderson J; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Scull B; Department of Pediatrics, Baylor College of Medicine, Texas Children's Cancer Center, Houston, TX, USA., Gurumurthy C; Mouse Genome Engineering Core Facility, University of Nebraska Medical Center, Omaha, NE, USA., Vega F; Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Chadburn A; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA., Cuglievan B; Department of Pediatrics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., El-Mallawany NK; Department of Pediatrics, Baylor College of Medicine, Texas Children's Cancer Center, Houston, TX, USA., Allen C; Department of Pediatrics, Baylor College of Medicine, Texas Children's Cancer Center, Houston, TX, USA., Mason C; Department of Medicine and Weill Cornell Cancer Center, Weill Cornell Medicine, New York, NY, USA., Melnick A; Department of Medicine and Weill Cornell Cancer Center, Weill Cornell Medicine, New York, NY, USA., Green MR; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: mgreen5@mdanderson.org.
Publikováno v:
Cancer cell [Cancer Cell] 2024 Apr 08; Vol. 42 (4), pp. 605-622.e11. Date of Electronic Publication: 2024 Mar 07.
Autor:
Root JL; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; School of Biomedical Informatics, The University of Texas Health Science Center, Houston, Texas., Desai PN; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; School of Biomedical Informatics, The University of Texas Health Science Center, Houston, Texas., Ly C; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; School of Biomedical Informatics, The University of Texas Health Science Center, Houston, Texas., Wang B; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Jelloul FZ; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Zhou J; IsoPlexis Corporation, Branford, Connecticut., Mackay S; IsoPlexis Corporation, Branford, Connecticut., Alfayez M; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Matthews J; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Pierce S; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Reville PK; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Daver N; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Abbas HA; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; School of Biomedical Informatics, The University of Texas Health Science Center, Houston, Texas.
Publikováno v:
Cancer research communications [Cancer Res Commun] 2024 Mar 06; Vol. 4 (3), pp. 671-681.
Autor:
Guo S; School of Basic Medical Sciences, Harbin Medical University, Harbin, Heilongjiang, China., Mohan GS; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Wang B; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Li T; School of Basic Medical Sciences, Harbin Medical University, Harbin, Heilongjiang, China., Daver N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Zhao Y; School of Basic Medical Sciences, Harbin Medical University, Harbin, Heilongjiang, China., Reville PK; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA habbas@mdanderson.org dapeng.hao@gmail.com pkreville@mdanderson.org., Hao D; School of Basic Medical Sciences, Harbin Medical University, Harbin, Heilongjiang, China habbas@mdanderson.org dapeng.hao@gmail.com pkreville@mdanderson.org., Abbas HA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA habbas@mdanderson.org dapeng.hao@gmail.com pkreville@mdanderson.org.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Feb 28; Vol. 12 (2). Date of Electronic Publication: 2024 Feb 28.
Autor:
Wang B; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Reville PK; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Yassouf MY; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jelloul FZ; Department of Hematopathology, Division of Pathology & Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ly C; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Desai PN; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; School of Biomedical Informatics, The University of Texas Health Science Center, Houston, TX, USA., Wang Z; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Borges P; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Biology and Biochemistry, University of Houston, Houston, TX, USA., Veletic I; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Dasdemir E; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Biology and Biochemistry, University of Houston, Houston, TX, USA., Burks JK; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tang G; Department of Hematopathology, Division of Pathology & Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Guo S; School of Basic Medical Sciences, Harbin Medical University, Harbin, Heilongjiang, China., Garza AI; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Nasnas C; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Vaughn NR; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Baran N; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Deng Q; Department of Lymphoma & Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Matthews J; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gunaratne PH; Department of Biology and Biochemistry, University of Houston, Houston, TX, USA., Antunes DA; Department of Biology and Biochemistry, University of Houston, Houston, TX, USA., Ekmekcioglu S; Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Sasaki K; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Garcia MB; Department of Pediatrics, Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Cuglievan B; Department of Pediatrics, Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hao D; School of Basic Medical Sciences, Harbin Medical University, Harbin, Heilongjiang, China., Daver N; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Green MR; Department of Lymphoma & Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Genomic Medicine, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Konopleva M; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Oncology, Albert Einstein College of Medicine, Bronx, NY, USA., Futreal A; Department of Genomic Medicine, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Post SM; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Abbas HA; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. habbas@mdanderson.org.; Department of Genomic Medicine, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. habbas@mdanderson.org.
Publikováno v:
Nature communications [Nat Commun] 2024 Feb 28; Vol. 15 (1), pp. 1821. Date of Electronic Publication: 2024 Feb 28.
Autor:
Desai PN; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.; School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, Texas., Wang B; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Fonseca A; Department of Biology and Biochemistry, University of Houston, Houston, Texas., Borges P; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Biology and Biochemistry, University of Houston, Houston, Texas., Jelloul FZ; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Reville PK; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Lee E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.; School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, Texas., Ly C; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.; School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, Texas., Basi A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Root J; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.; School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, Texas., Baran N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Post SM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Deng Q; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas., Sun H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Harmanci AO; School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, Texas., Burks JK; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Gomez JA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Daver NG; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Alatrash G; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas., Konopleva M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Green MR; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Antunes DA; Department of Biology and Biochemistry, University of Houston, Houston, Texas., Futreal A; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Hao D; School of Basic Medical Sciences, Harbin Medical University, Harbin, China., Abbas HA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Publikováno v:
Cancer immunology research [Cancer Immunol Res] 2023 Jun 07, pp. OF1-OF18. Date of Electronic Publication: 2023 Jun 07.
Autor:
Desai PN; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Wang B; The University of Texas MD Anderson Cancer Center, United States., Fonseca A; University of Houston, United States., Borges P; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Jelloul FZ; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Reville PK; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Lee E; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Ly C; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Basi A; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Root J; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Baran N; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Post SM; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Deng Q; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Sun H; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Harmanci AO; The University of Texas Health Science Center at Houston, United States., Burks JK; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Gomez JA; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., DiNardo CD; MD Anderson Cancer Center, University of Texas, Houston, TX, United States., Daver NG; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Alatrash G; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Konopleva M; Albert Einstein College of Medicine, Bronx, New York, United States., Green MR; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Antunes DA; University of Houston, United States., Futreal A; The University of Texas MD Anderson Cancer Center, Houston, United States., Hao D; Harbin Medical University, Harbin, China., Abbas HA; The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Publikováno v:
Cancer immunology research [Cancer Immunol Res] 2023 May 10. Date of Electronic Publication: 2023 May 10.
Autor:
Kadia TM; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Reville PK; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX., Wang X; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX., Rausch CR; Department of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX., Borthakur G; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Pemmaraju N; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Daver NG; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., DiNardo CD; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Sasaki K; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Issa GC; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Ohanian M; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Montalban-Bravo G; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Short NJ; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Jain N; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Ferrajoli A; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Bhalla KN; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Jabbour E; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Takahashi K; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Malla R; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Quagliato K; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Kanagal-Shamanna R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Popat UR; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX., Andreeff M; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Garcia-Manero G; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Konopleva MY; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Ravandi F; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Kantarjian HM; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2022 Nov 20; Vol. 40 (33), pp. 3848-3857. Date of Electronic Publication: 2022 Jun 15.
Autor:
Lachowiez CA; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Reville PK; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Daver N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Issa G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Furudate K; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Tanaka T; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Pierce S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Tang G; Department of hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Patel KP; Department of hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Medeiros J; Department of hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Abbas HA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Haddad F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Hammond D; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Short NJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Maiti A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Yilmaz M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Sasaki K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Takahashi K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Pemmaraju N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Konopleva M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Kadia TM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Loghavi S; Department of hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Publikováno v:
American journal of hematology [Am J Hematol] 2022 Nov; Vol. 97 (11), pp. 1443-1452. Date of Electronic Publication: 2022 Sep 15.
Autor:
Lachowiez CA; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Reville PK; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Daver N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Loghavi S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Furudate K; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Xiao L; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Pierce S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Short NJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Maiti A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Yilmaz M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Sasaki K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Takahashi K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Konopleva M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Pemmaraju N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Popat U; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Shpall E; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kadia TM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: tkadia@mdanderson.org.
Publikováno v:
The Lancet. Haematology [Lancet Haematol] 2022 May; Vol. 9 (5), pp. e350-e360.